The shift from reactive disease treatment to proactive immunization programs is a fundamental economic calculation for Italian poultry producers, moving health spending from an emergency cost to a strategic investment. The return on investment (ROI) for comprehensive prophylactic schedules is increasingly viewed through a 'One Health' economic framework, recognizing that savings extend far...
As of January 2026, the Italy poultry vaccines market is identifying as a critical defensive barrier for Europe's food security, with an estimated valuation of approximately $70 million this year. The 2026 landscape is defined by the intensifying fight against Highly Pathogenic Avian Influenza (HPAI), particularly the H5N1 strain, which saw its first major 2025/2026 seasonal cases confirmed in...
In Italian poultry farming, diagnostic testing is an indispensable component of any successful prophylactic strategy, serving as both a preliminary risk assessment tool and a post-intervention audit. Prior to immunization, surveillance testing (serology and molecular diagnostics) is crucial for identifying circulating pathogens, determining the exact strain present, and confirming the specific...